Matt Fust

Audit Committee Chair

Ultragenyx Pharmaceutical

Current public company boards: Atara Biotherapeutics, Crinetics Pharmaceuticals, Ultragenyx Pharmaceutical

Prior public company boards: Dermira Inc, Macrogenics Inc, Sunesis Pharmaceuticals

Executive Experience: Matt Fust is a board member and advisor to life sciences companies.

From 29 through 213, he was CFO of Onyx Pharmaceuticals, culminating in the company’s sale to Amgen. He previously served as CFO of Jazz Pharmaceuticals (23 – 28), CFO of Perlegen Sciences (22 – 23), and CFO of ALZA Corporation, where he was an executive from 1996 through the company’s acquisition by Johnson & Johnson in 21. Prior to joining ALZA, Matt was a manager in the healthcare strategy consulting practice at Andersen Consulting (now Accenture).

Matt serves on the boards and audit committees of Atara Biotherapeutics, BlackThorn Therapeutics, Crinetics Pharmaceuticals, Dermira, MacroGenics, and Ultragenyx Pharmaceutical. He also advises life sciences companies on corporate strategy and finance topics.

Additional information: Matt holds an undergraduate degree in accounting from the University of Minnesota, and an MBA from the Stanford University Graduate School of Business.